Viewing StudyNCT00077363



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00077363
Status: COMPLETED
Last Update Posted: 2013-02-27
First Post: 2004-02-10

Brief Title: Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: NCI-2012-02973
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Cancer Institute NCI
Lead Sponsor Class: NIH
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators